Gender Differences in Experimental Aortic Aneurysm Formation

From Jobst Vascular Research Laboratories, Section of Vascular Surgery (G.A., J.L.E., K.J.R., I.S., K.K.H., P.K.H., J.C.S., G.R.U.), Section of Transplant Surgery (G.L.), Department of Pathology (E.P.K.), and Division of Molecular Medicine and Genetics, Department of Internal Medicine (S.J.W.), University of Michigan Medical School, Ann Arbor; and the Section of Vascular Surgery, Department of Surgery and Department of Cell Biology and Physiology (R.W.T.), Washington University Medical School, St Louis, Missouri.

ABSTRACT

Objective— It is hypothesized that a male predominance, similar to that in humans, persists in a rodent model of experimental abdominal aortic aneurysm (AAA) via alterations in matrix metalloproteinases (MMPs).

Methods and Results— Group I experiments were as follows: elastase perfusion of the infrarenal aorta was performed in male (M) and female (F) rats. At 14 days, aortas were harvested for immunohistochemistry, real-time polymerase chain reaction (PCR), and zymography. Group II experiments were the following: abdominal aorta was transplanted from F or M donors into F or M recipients. At 14 days, rodents that had undergone transplantation underwent elastase perfusion. In group III, male rats were given estradiol or sham 5 days before elastase perfusion. In group I, M rats had larger AAAs with higher frequency than did F rats. M rat aortas had more significant macrophage infiltrates and increased matrix metalloproteinase (MMP)-9 production and activity. In group II, M-to-M aortic transplants uniformly developed aneurysms after elastase perfusion, whereas F-to-F aortic transplants remained resistant to aneurysm formation. F aortas transplanted into M recipients, however, lost aneurysm resistance. In group III, estradiol-treated rats demonstrated smaller aneurysms and less macrophage infiltrate and MMP-9 compared with M controls after elastase.

Conclusions— These data provide evidence of gender-related differences in AAA development, which may reflect an estrogen-mediated reduction in macrophage MMP-9 production.

Male rats demonstrated larger aortic dilatation than females after elastase exposure. Next, female rat aortas transplanted into males after elastase exposure lost aneurysm resistance. Finally, estradiol inhibited experimental aneurysm formation. Aneurysms correlated with increased macrophage and MMP-9 infiltration. Gender-related differences in aneurysms may be estrogen-mediated via reductions in macrophage MMP-9.

Key Words: aorta ? aneurysm ? genetic ? estrogen ? metalloproteinase

Introduction

Abdominal aortic aneurysms (AAAs) are potentially life-threatening, accounting for 150 000 hospital admissions yearly.1 Clear gender differences exist, with a prevalence in men 4-times that in women.2,3 The diminished risk of AAA development is lost in women after menopause, suggesting that reproductive events, including circulating estrogens, may play a protective role.4,5

Prominent local inflammatory cell infiltration, aortic wall cytokine production, medial wall destruction by proteinases, and smooth muscle cell depletion characterize most AAAs. Destruction of elastin and collagen in the media by various matrix metalloproteinases (MMPs) is considered an essential element of AAA formation.6–8 MMP-1, MMP-2, MMP-3, MMP-9, MMP-12, as well as tissue inhibitor of metalloproteinase-1, are all upregulated in the walls of human AAAs.9–14 Two of these, MMP-2 and MMP-9, have been extensively studied. MMP-9 has attracted particular attention in that it is highly expressed in human AAA wall and is present in serum from AAA patients.14,15 Mice with deletion of the gene responsible for the MMP-9 protein are resistant to the development of experimental AAAs.10 In addition, MMP-2, derived from aortic mesenchymal cells, appears necessary for experimental aneurysm formation.16

Many studies implicating MMPs in AAA evolution have used a rat or mouse model with porcine pancreatic elastase perfusion of the infrarenal aorta. This model causes an initial influx of macrophages and lymphocytes leading to destruction and remodeling of the aortic wall matrix, and subsequent aneurysm development.17 Atherosclerosis, only once considered an essential to aneurysm development, is not thought to be the mechanism responsible for AAA formation.18,19 Importantly, nearly all previous studies have been performed using male rodents. To date, the influence of gender on experimental AAA formation has received little attention. Furthermore, although estrogen is known to affect collagen and elastin matrix remodeling in rats,20 its role in AAA formation has not been studied. This investigation was designed to determine the relevance of male and female gender on experimental AAA formation and to define local and systemic events that might influence any anticipated differences related to gender.

Methods

Sprague-Dawley rats (200 to 250 grams, age 8 to 10 weeks), obtained from Charles River Laboratories (Wilmington, Mass), were used in all experiments. Procedures and experiments were approved by the University of Michigan Universal Committee on the Use and Care of Animals (#8220 and #8314).

Elastase Perfusion Aneurysm Model

Pancreatic porcine elastase perfusion of the rat aortas was performed as described previously.17 Male and female rats (n=15, each) were anesthetized with 2 to 2.5% isoflurane inhalation, and the infrarenal abdominal aorta was isolated under sterile conditions. Digital video micrometry was performed to directly measure outer aortic diameter. Specifically, images of the aorta were obtained using a Spot Insight Color Optical Camera (Diagnostic Instruments, Sterling Heights, Mich) attached to an operating microscope (Nikon, Melville, NY). Aortic diameters were then measured at the level of the left renal vein, the mid-infrarenal aorta, and the aortic bifurcation in triplicate using Image Pro Express software (Media Cybernetics Inc, Silver Spring, Md). Temporary proximal and distal aortic control was obtained using temporary 4-0 cotton suture loops, following which an aortotomy was made near the aortic bifurcation with a 30-gauge needle. The infrarenal aorta was cannulated with PE-10 tubing and perfused with 12 U of porcine pancreatic elastase diluted to a total volume of 2 mL with sterile normal saline (Lot #032K7660 or Lot #102K685; Sigma, St. Louis, Mo) over 60 minutes. Subsequently, the tubing was removed and the aortotomy repaired with 10-0 monofilament suture. Patency was assured in all cases. Aortic diameter measurements were repeated immediately after perfusion. The intestines were replaced; the abdominal wall was closed; and the rats were recovered. At 7 or 14 days, aortas were re-exposed and aortic diameters were re-measured in vivo. Aneurysm formation was defined as a 100% increase in an individual animal’s pre-elastase perfusion aortic diameter. The infrarenal aorta was then removed and subjected to histological study, immunohistochemistry, and quantitative polymerase chain reaction (PCR).

Aortic Transplantation

In additional rats, transplantation of the infrarenal rat aorta was performed as previously described.21 Briefly, male and female donor rats were anesthetized and the abdominal aortas isolated. Donor rats were anticoagulated with 300 U of heparin and the abdominal aorta was rapidly removed and placed in cold 0.9% normal saline. The recipient rats’ infrarenal abdominal aortas were similarly isolated and proximal and distal aortic control was obtained with temporary 4-0 cotton suture loops. The recipient abdominal aorta was excised and donor abdominal aorta was transplanted into the infrarenal position of a size-matched recipient using a running 10-0 monofilament suture in an end-to-end fashion. After aortic patency was assured, the abdominal incision was closed and rats were recovered.

Female donor aortas were transplanted into male recipients (n=7) with controls including female aortas transplanted into female recipients (n=7) and male aortas transplanted into male recipients (n=9). Fourteen days after transplantation, the transplanted aortas were subjected to pancreatic porcine elastase perfusion and harvested after 14 days as previously noted.

Estrogen Pellet Implantation

In other experiments, male rats were randomized to implantation of an estrogen pellet or sham implantation (n=13, each). The former involved the subcutaneous implantation of a 21-day slow-release 0.1-mg 17?-estradiol pellet (Innovative Research of America, Sarasota, Fla) in the posterior neck. Sham rats underwent the same implantation procedure without insertion of any pellet. This particular estradiol dose results in serum estradiol levels at 2 to 3 weeks of 44.7±6.1 pg/mL compared with 15.0±2.2 pg/mL in control rats (P<0.05).22 Rat aortas from both groups were subjected to elastase perfusion 5 days later. The aortas were then removed for study 7 or 14 days after elastase perfusion.

Histological Analysis

All excised aortas were fixed in 10% formalin for 18 hours, followed by immersion in 70% ethanol for 24 hours. Aortas were then imbedded in paraffin and 4-μm sections were prepared with hematoxylin and eosin and Verhoeff-Van Gieson stains.

Immunohistochemistry was undertaken after deparaffinization, rehydration, and unmasking using Trilogy (Cell Marque Corp, Hot Springs, Ariz) in a Princess model pressure cooker (Cell Marque). Endogenous peroxidase activity was then blocked using 3% hydrogen peroxide in methanol. To help ensure that rejection was not occurring in elastase-perfused or transplanted animals, anti-T lymphocyte immunohistochemistry was performed. Specifically, antirat CD3 monoclonal antibody (BD Pharmingen, San Diego, Calif) was used as the primary antibody and mouse IgG Vectastain (Vector Laboratories, Burlingame, Calif) as the secondary antibody. Rat spleen was used as the positive control for anti-CD3 staining. ED-1 macrophage staining was performed using mouse antirat ED-1 primary antibody (Serotec, Raleigh, NC) and mouse IgG Vectastain secondary antibody (Vector Laboratories). MMP-9 immunohistochemistry was performed using rabbit antirat MMP-9 polyclonal primary antibody (Chemicon International, Temecula, Calif) and rabbit IgG Vectastain secondary antibody (Vector Laboratories). Staining for all these antibodies was performed using Vector Red alkaline phosphatase (Vector Laboratories) followed by hematoxylin QS counterstain (Vector Laboratories).

Colocalization studies involved deparaffinization, rehydration, and unmasking as previously described. Endogenous peroxidase activity was blocked using 3% hydrogen peroxide in methanol. Staining for ED-1 was performed using mouse antirat ED-1 primary antibody (Serotec), mouse IgG Vectastain secondary antibody (Vector Laboratories), and Vector Blue alkaline phosphatase. Samples were stored in PBS at 4°C overnight. The next day, staining for MMP-9 was performed using rabbit antirat MMP-9 polyclonal primary antibody AB19016 (Chemicon International), rabbit IgG Vectastain secondary antibody (Vector Laboratories), and Vector Red alkaline phosphatase stain.

Quantitative PCR

Expression of MMP-9 and ?-actin mRNA was determined using quantitative PCR. Messenger RNA was isolated by exposure of aortas to TRIzol reagent and reverse-transcribed by incubating with oligo-dT primer (Life Technologies, Grand Island, NY) and M-MLV Reverse Transcriptase (Life Technologies, Grand Island, NY) at 94°C for 3 minutes, followed by 40°C for 70 minutes. The resultant cDNA was amplified by Taq Polymerase (Promega, Madison, Wis) in a SmartCycler quantitative PCR system (Cepheid, Sunnyvale, Calif). SYBR intercalating dye (Roche, Indianapolis, Ind) was used to monitor cDNA amplification for each gene. MMP-9 and ?-actin primer sequences were derived using Primer Premeir software (PREMIER Biosoft International, Palo Alto, Calif) based on primary cDNA sequences from GenBank (http://www.ncbi.nlm.nih.gov/Genbank/). Primer sequences are as follows: MMP-9 forward primer, CGC CAA CTA TGA CCA GGA TA; MMP-9 reverse primer, GTT GCC CCC AGT TAC AGT; ?-actin forward primer, ATG GGT CAG AAG GAT TCC TAT GTG; ?-actin reverse primer, CTT CAT GAG GTA GTC AGT CAG GTC. Results were normalized using ?-actin to account for variation in mRNA amounts. Quantification of mRNA levels used Ct values, calculated by the formula:

Expression of the target gene in ratio to ?-actin expression was calculated by the formula:

Substrate Gel Zymography

MMP-9 distribution after elastase perfusion was determined by zymography as previously described.23 Gelatinase activity was evident by clear bands against a dark blue background. The molecular weight of each band was determined by comparison of the bands against samples containing human recombinant MMP-9 (Oncogene, Boston, Mass). In previous studies, these bands were inhibited by EDTA and are thus metalloproteinases.23 Semiquantitative measurements were performed using densitometry as described and normalized to total protein.

Densitometry

Gels were imaged with a FOTO/Analyst charge-coupled device CAMERA (Fotodyne, Hartland, Wis). Band strengths were quantified using GEL-Pro Analyzer software version 3.1 (Media Cybernetics, Silver Springs, Md).

Total Protein Assay

Total cellular protein was determined by a bicinchoninic acid protein assay (Pierce, Rockford, Ill) in aortas on which MMP-9 activity assays were performed after they had been solubilized in 0.1% sodium dodecyl sulfate.

Data Analysis

Data are represented as mean±SE. Data were assessed by nonpaired t test or ANOVA with statistical significance assigned as P<0.05. When significance was reached, post hoc Tukey test was used to compare individual groups. Statistical analysis was performed using Prism software (GraphPad Software, San Diego, Calif).

Results

Baseline Histology in Male Versus Female Rats

Male and female rats’ aortas not subjected to any intervention were harvested and subjected to histological analysis. Male and female aortas were nearly identical in wall thickness and aortic lamellar structure (data not shown) by Verhoeff-Van Gieson stain. Aortas from both genders were indistinguishable by an experienced pathologist (E.P.K). CD3 immunohistochemistry demonstrated little to no lymphocytic infiltrate in the aortas of either males or females (data not shown).

Experimental AAA Formation in Male Versus Female Rats

Preperfusion baseline aortic diameters were not different (P=0.20) between male and female aortas (1.41±0.16 versus 1.32±0.07, respectively). The mean increase in aortic diameter 14 days after elastase perfusion in male aortas was 200±37.6%, whereas female aortas had a mean aortic diameter increase of 69.4±26.5% (P=0.0234; Figure 1a). The incidence of AAAs defined as an increase in aortic diameter at least 100% from preperfusion diameter was 82% in male rats compared with 29% in female rats (P=0.0229; Figure 1a).

Figure 1. Male and female aortas 14 days after elastase perfusion. a, Percent increase in aortic diameter in male (M) and female (F) aortas 14 days after elastase perfusion compared with baseline aortic diameter. M had significantly larger AAAs (P=0.0234) and higher incidence of AAAs (P=0.0229) compared with F. MMP-9 immunohistochemical staining in M (b) and F (c) aorta after elastase perfusion (100x). Positive staining regions (arrows) are more prominent in M. Colocalization for ED-1 (blue) and MMP-9 (red) demonstrates more prominent costaining in M (d) and F (e) (100x). MMP-9 staining appeared associated with ED-1-positive staining cells.

Male aneurysmal aortas exhibited circumferential disruption of the elastic lamellae 14 days after elastase perfusion, whereas the aortas of female rats after elastase perfusion had largely intact elastin fibers (please see www.ahajournals.org). CD3 staining demonstrated minimal lymphocyte infiltration in either male or female aortas (data not shown). ED-1-positive cells were located primarily in the adventitia and media, consistent with previous reports.10 Macrophage infiltration was more prominent in the male aortas, where ED-1-positive cell counts were 6.2±1.0 cells/high-powered field (HPF) compared with 0.54±0.02 cells/HPF in female aortas (P=0.003; please see www.ahajournals.org).

MMP-9 staining was also more evident in the media and adventitia of male aortas compared with female aortas, as evidenced by immunohistochemistry (Figure 1b and 1c). Colocalization of ED-1 and MMP-9 demonstrated increased costaining of macrophages and MMP-9 in male aortas versus female aortas (Figure 1d and 1e). Similarly, male aortas exhibited increased MMP-9 expression by quantitative PCR compared with female aortas (males, 0.39±0.09 versus 0.003±0.001 MMP-9 mRNA copies; P=0.001; please see www.ahajournals.org). Total MMP-9 activity by zymography was 369% greater in male than female aortas (P=0.022; please see www.ahajournals.org).

Aneurysm-Resistant Phenotype Is Lost After Transplantation of the Female Into the Male

All male and female aortas, when transplanted into male recipients and subsequently subjected to elastase perfusion, developed AAAs at 14 days, whereas only 17% of the female aortas transplanted into female recipients developed AAAs. Aortic dilations were similar among male-to-male and female-to-male transplanted aortas, but were significantly lower in the female-to-female transplanted aortas (male-to-male transplants, 189±22%; female-to-male transplants, 197±34%; female-to-female transplants, 93±13%; P=0.0118;Figure 2a). Thus, although female aortas transplanted into female recipients remained resistant to AAA, when transplanted into male rats, the observed female resistance was lost.

Figure 2. Transplanted aortas subjected to elastase perfusion. a, Percent increase in aortic diameter in transplanted animals after elastase perfusion compared with baseline aortic diameter before aneurysm induction. All male-to-male transplanted aortas after elastase perfusion (MMtx) developed AAAs, whereas female-to-female transplanted aortas (FFtx) remained AAA-resistant. Female-to-male transplanted aortas (FMtx) uniformly developed AAAs (P=0.0118). Immunohistochemistry for MMP-9 (red) demonstrates more staining in MMtx (b) and FMtx (c) than in FFtx (d) (100x). Colocalization of ED-1 (blue) and MMP-9 (red) demonstrates prominent costaining in MMtx (e), less staining in FFtx (f), and more prominent costaining in FMtx (g) (100x).

Male-to-male transplants revealed near-total destruction of the aortic medial elastic lamellar structure, whereas female-to-female transplants had more elastin preservation (data not shown). Female-to-male transplants followed a similar pattern as male-to-male transplants with near-total destruction of the elastic lamellar structure (please see www.ahajournals.org). Importantly, CD3 staining demonstrated minimal lymphocyte infiltration in any of the transplanted groups (data not shown). However, ED-1-positive macrophage staining was prominent in the media and adventitia of male-to-male and female-to-male transplanted aortas and less evident in female-to-female transplanted aortas (please see www.ahajournals.org). ED-1-positive macrophages, when quantified, were significantly higher in the male-to-male (68.5±7.4 cells/HPF) and female-to-male transplanted aortas (36.0±1.2 cells/HPF) when compared with female-to-female transplanted aortas (22.4±2.0 positive cells/HPF; P=0.0002). MMP-9 staining was more prominent in male-to-male and female-to-male transplanted aortas transplanted aortas than female-to-female transplanted aortas (Figure 2b to 2d). Colocalization of ED-1 and MMP-9 demonstrated more costaining in male-to-male transplanted aortas and female-to-male transplanted aortas compared with female-to-female transplanted aortas (Figure 2e to 2g). MMP-9 mRNA, assessed by quantitative PCR, was also higher in the former aortas (male-to-male transplanted aortas, 0.050±0.002 mRNA copies; female-to-male transplanted aortas, 0.034±0.007mRNA copies) than in female-to-female transplanted aortas (0.005±0.002 mRNA copies, P=0.0175; please see www.ahajournals.org).

Estradiol Effects on Aneurysmal Development

Moderate aortic expansion at 7 days occurred in male rats receiving estradiol and sham control rats being 124%±19% versus 197%±39%, respectively (P=0.010). By 14 days, male rats receiving estradiol had significantly smaller aneurysms (241% ± 57) compared with sham rats (538%±105, P=0.0226; Figure 3a). Elastin fragmentation was less prominent in estradiol treated rats’ aortas (please see www.ahajournals.org). ED-1-positive cell counts were 1.8±0.3 cells/HPF in those receiving estradiol versus 5.2±0.5 cells/HPF in sham rats (P=0.0006). Aortic MMP-9 staining was also less evident in the estradiol treated rats compared with the sham rats (Figure 3b and 3c). Colocalization of aortic ED-1 and MMP-9 demonstrated less prominently stained cells in rats treated with estradiol compared with sham rats (Figure 3d and 3e). By 7 days after elastase perfusion, estradiol-treated rats exhibited less aortic MMP-9 mRNA expression (0.0017±0.004 mRNA copies) compared with sham rats (0.12±0.04 mRNA copies, P=0.11, please see www.ahajournals.org).

Figure 3. Estradiol-treated male aortas subjected to elastase perfusion. a, Percent increase in aortic diameter in male sham (MS) and male estradiol-treated (ME) rats before elastase perfusion and at 7 and 14 weeks after elastase perfusion. By 14 days, ME had significantly smaller AAAs (P=0.0226). Immunohistochemical staining for MMP-9 (red, arrow) was more extensive in MS (b) compared with ME (c) (100x). Colocalization of ED-1 (blue) and MMP-9 (red) demonstrates more prominent staining in MS (d) than ME (e) (100x).

Discussion

This investigation documents that female rats are partially protected from experimental AAA formation, and male rats consistently form larger AAAs. Female rat aortas subjected to elastase perfusion exhibited less medial wall destruction, fewer infiltrating macrophages, and decreased MMP-9. Furthermore, MMP-9 expression was also decreased in the aortas of these female rats.

The apparent protection that female aortas exhibited in situ was lost after their transplantation into the male rat, whereas the female aortas transplanted into other female rats maintained their aneurysm resistance. Factors affecting the cardiovascular system, such as increased circulating estrogen known to be present in females, may be potentially associated with the observed AAA resistance.24,25

Numerous studies support a lower incidence of AAA in women compared with men.23,26 In addition, AAAs in women occur nearly a decade later than they do in men, although they are more often juxtarenal compared with infrarenal AAAs.27 Nonetheless, women have up to 4 times the risk of rupture and death compared with men,28,29 and have nearly 3-times the complication rate after AAA repair compared with men.30 Thus, whereas AAAs occur more frequently in men, the clinical sequelae of this disease in women are more disastrous.

To our knowledge, only 1 other study has examined both male and female animals in this experimental AAA model. Lee et al demonstrated no protection from experimental AAA formation in male inducible nitric oxide synthase (iNOS–/–) knockout mice, whereas female iNOS–/– mice had enhanced aortic expansion.31 Although this study did not evaluate MMPs, it did suggest a gender-related effect of nitric oxide on experimental AAA formation.

The protective role of estrogen and its derivatives during AAA formation receives indirect support from a number of earlier studies. Animals treated with estradiol appear to have increased prostacyclin levels, resulting in improved vasorelaxation32 and decreased vascular smooth muscle cell (VSMC) contractility compared with male controls.33 In addition, estradiol inhibits medial smooth muscle cell proliferation.34 In an apolipoprotein E-deficient murine model, estradiol was shown to attenuate the development of AAAs.35 Furthermore, in postmenopausal women, phytoestrogens result in decreased aortic stiffness.36 Thus, estrogen has multiple effects in humans and experimental animals that may be protective against aneurysm development. Embryological aortic development occurs before hormonal variation that occurs during puberty. No apparent differences between male and female native rodent aortas are present histologically. This suggests that estrogens may not act in aortic development, but rather to maintain structure and prevent aortic dilatation. This is supported by the observation that women appear to have a delay in their development of abdominal aortic aneurysms until after menopause.

It is generally accepted that macrophages are the primary source for MMP-9 in experimental and human AAAs. In the current investigation, estradiol inhibited aortic macrophage infiltration and MMP-9 production. Thus, estradiol may effect AAA development by indirectly inhibiting the influx of macrophages and directly by its inhibitory effect on macrophage and smooth muscle cell production of MMPs. Recently, estrogen treatment of U937 cells have been shown to decrease MMP-2 production.37 Estrogen may effect MMP-9 similarly.

The effect of estradiol on macrophages and the immune system is not novel. For instance, it has been shown that estrogen has a direct inhibitory effect on macrophage recruitment, as well as on monocyte chemoattractant protein-1.38–41 In a mouse encephalitis model, estrogen inhibited monocyte infiltration into the inflamed tissue. Furthermore, increased estrogen levels in women, including those using estrogen replacement therapy, correlated with reductions in circulating monocyte chemoattractant protein-1 levels. These data support speculation that estrogens may inhibit macrophage infiltration, MMP-9 expression, and subsequent destruction of the aortic wall.

Certain limitations exist in the current investigation. First, elastase perfusion of the aorta has been argued to be an acute, rapid model of AAA formation that may not mimic human AAA development. Nonetheless, the primary cell involved in the elastase model is the macrophage, which is the primary source for MMP-9 in human AAAs.14,42 Other cells that may be involved, such as smooth muscle cells, were consequently not examined in this investigation. In addition, many other proteases known to be upregulated in human AAAs and that are consistently elevated in elastase-perfused experimental AAAs were not examined in the present study. This does not preclude a role for other cell types or other proteases in the observed gender-related differences in experimental AAA formation. Second, transplantation of the aorta, although designed to alter the hormonal environment of the donor aorta, may in and of itself result in a local inflammation in the retroperitoneum. Previous work by Ailawadi et al suggests that ED-1-positive cells are increased after transplantation compared with native aortic explants.21 The lack of CD3-positive lymphocytes and the few architectural differences other than those described does suggest that rejection is not involved in this process after transplantation or elastase perfusion. Despite this lack of perceived differences, comparisons between transplanted elastase-perfused aortas and nontransplanted elastase-perfused aortas cannot be made. Third, 2 different lots of elastase were used in the present investigation and may have resulted in varied results. The first lot was used for elastase perfusion of aortas in the first and second group of experiments (intact and transplanted animals), whereas the latter lot was used for the third group of experiments (those treated with estradiol). These elastase lots were quite different, in as much as the nontransplanted and transplanted elastase-perfused male aortas increased their aortic diameter by 200%, whereas elastase-perfused male aortas used in the estradiol-treatment experiments developed almost 500% increases in their aortic diameter using a different lot of elastase. Such variation has been reported with different lots of elastase despite uniform dose and activity.43 As a consequence, groups treated with different lots of elastase should not be compared, with comparisons limited only to animals treated with the same lot of elastase.

Despite these limitations, this investigation supports the theory that gender differences in experimental AAA formation exist that may be related to estrogenic effects on macrophages and MMPs. Gender differences in other cell lines and proteases, as well as cytokines, must be better-evaluated to further completely characterize the disparity between men and women with regard to AAA formation. The efficacy of estradiol will need to be better-delineated before the institution of this or related hormones as a potential therapeutic agent.

Acknowledgments

Funded by an American College of Surgeons Resident Research Scholarship and National Institutes of Health Training Grant in Molecular and Cellular Cardiology T32-HL07853-05 (to G.A.); Society of University Surgeons Junior Faculty Award (to P.K.H.); University of Michigan McKay Grant, National Institutes of Health Mentored Clinician Scientists Development Award (K08 HL67885-01), and the Lifeline Foundation Research Award (to G.R.U.), and Jobst Vascular Research Fund (to P.K.H., J.C.S., and G.R.U.).

References

National Hospital Discharge Survey Data. http://www.cdc.gov/nchs/data/series/sr_13/sr13_153.pdf. Hyattsville, Md: National Center for Health Statistics; Updated November, 2002.

Pleumeekers HJ, Hoes AW, van der DE, van Urk H, Hofman A, de Jong PT, Grobbee DE. Aneurysms of the abdominal aorta in older adults. The Rotterdam Study. Am J Epidemiol. 1995; 142: 1291–1299.

Singh K, Bonaa KH, Jacobsen BK, Bjork L, Solberg S. Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study: The Tromso Study. Am J Epidemiol. 2001; 154: 236–244.

Bengtsson H, Sonesson B, Bergqvist D. Incidence and prevalence of AAA. Ann NY Acad Sci. 1996; 800: 1–24.

La Vecchia C, Decarli A, Franceschi S, Gentile A, Negri E, Parazzini F. Menstrual and reproductive factors and the risk of myocardial infarction in women under fifty-five years of age. Am J Obstet Gynecol. 1987; 157: 1108–1112.

Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1995; 15: 1145–1151.

Tamarina NA, McMillan WD, Shively VP, Pearce WH. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery. 1997; 122: 264–271.

Thompson RW, Parks WC. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann NY Acad Sci. 1996; 800: 157–174.

Allaire E, Forough R, Clowes M, Starcher B, Clowes AW. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest. 1998; 102: 1413–1420.

Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM, Thompson RW. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest. 2000; 105: 1641–1649.

Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest. 1998; 102: 1900–1910.

Carrell TW, Burnand KG, Wells GM, Clements JM, Smith A. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation. 2002; 105: 477–482.

Davis V, Persidskaia R, Baca-Regen L, Itoh Y, Nagase H, Persidsky Y, Ghorpade A, Baxter BT. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 1998; 18: 1625–1633.

Thompson RW, Holmes DR, Mertens RA, Liao S, Botney MD, Mecham RP, Welgus HG, Parks WC. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest. 1995; 96: 318–326.

McMillan WD, Pearce WH. Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg. 1999; 29: 122–127.

Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest. 2002; 110: 625–632.

Anidjar S, Salzmann JL, Gentric D, Lagneau P, Camilleri JP, Michel JB. Elastase-induced experimental aneurysms in rats. Circulation. 1990; 82: 973–981.

Agmon Y, Khandheria BK, Meissner I, Schwartz GL, Sicks JD, Fought AJ, O’Fallon WM, Wiebers DO, Tajik AJ. Is aortic dilatation an atherosclerosis-related process? Clinical, laboratory, and transesophageal echocardiographic correlates of thoracic aortic dimensions in the population with implications for thoracic aortic aneurysm formation. J Am Coll Cardiol. 2003; 42: 1076–1083.

Shteinberg D, Halak M, Shapiro S, Kinarty A, Sobol E, Lahat N, Karmeli R. Abdominal aortic aneurysm and aortic occlusive disease: a comparison of risk factors and inflammatory response. Eur J Vasc Endovasc Surg. 2000; 20: 462–465.

Fischer GM, Swain ML. Influence of contraceptive and other sex steroids on aortic collagen and elastin. Exper Mol Pathol. 1980; 33: 15–24.

Ailawadi G, Knipp BS, Lu G, Roelofs KJ, Ford JW, Hannawa KK, Bishop K, Thanaporn P, Henke PK, Stanley JC, Upchurch GR, Jr. A nonintrinsic regional basis for increased infrarenal aortic MMP-9 expression and activity. J Vasc Surg. 2003; 37: 1059–1066.

Brooks-Asplund EM, Shoukas AA, Kim SY, Burke SA, Berkowitz DE. Estrogen has opposing effects on vascular reactivity in obese, insulin-resistant male Zucker rats. J Appl Physiol. 2002; 92: 2035–2044.

Eagleton MJ, Peterson DA, Sullivan VV, Roelofs KJ, Ford JA, Stanley JC, Upchurch GR Jr. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression. J Surg Res. 2002; 104: 15–21.

Leinwand LA. Sex is a potent modifier of the cardiovascular system. J Clin Invest. 2003; 112: 302–307.

Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999; 340: 1801–1811.

Katz DJ, Stanley JC, Zelenock GB. Gender differences in abdominal aortic aneurysm prevalence, treatment, and outcome. J Vasc Surg. 1997; 25: 561–568.

Velazquez OC, Larson RA, Baum RA, Carpenter JP, Golden MA, Mitchell ME, Pyeron A, Barker CF, Fairman RM. Gender-related differences in infrarenal aortic aneurysm morphologic features: issues relevant to Ancure and Talent endografts. J Vasc Surg. 2001; 33 (suppl): 84.

Brown PM, Zelt DT, Sobolev B. The risk of rupture in untreated aneurysms: the impact of size, gender, and expansion rate. J Vasc Surg. 2003; 37: 280–284.

Dimick JB, Stanley JC, Axelrod DA, Kazmers A, Henke PK, Jacobs LA, Wakefield TW, Greenfield LJ, Upchurch GR Jr. Variation in death rate after abdominal aortic aneurysmectomy in the United States: impact of hospital volume, gender, and age. Ann Surg. 2002; 235: 579–585.

Wolf YG, Arko FR, Hill BB, Olcott C, Harris EJ Jr, Fogarty TJ, Zarins CK. Gender differences in endovascular abdominal aortic aneurysm repair with the AneuRx stent graft. J Vasc Surg. 2002; 35: 882–886.

Lee JK, Borhani M, Ennis TL, Upchurch GR Jr, Thompson RW. Experimental abdominal aortic aneurysms in mice lacking expression of inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol. 2001; 21: 1393–1401.

Bolego C, Cignarella A, Ruzza R, Zaarour C, Messi E, Zanisi M, Puglisi L. Differential effects of low- and high-dose estrogen treatments on vascular responses in female rats. Life Sciences. 1997; 60: 2291–2302.

Murphy JG, Khalil RA. Gender-specific reduction in contractility and (i) in vascular smooth muscle cells of female rat. Am J Physiol Cell Physiol. 2000; 278: C834–C844.

Sullivan TR Jr, Karas RH, Aronovitz M, Faller GT, Ziar JP, Smith JJ, O’Donnell TF Jr, Mendelsohn ME. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest. 1995; 96: 2482–2488.

Martin-McNulty B, Tham DM, da C, V, Ho JJ, Wilson DW, Rutledge JC, Deng GG, Vergona R, Sullivan ME, Wang YX. 17?-estradiol attenuates development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2003; 23: 1627–1632.

van der Schouw YT, Pijpe A, Lebrun CE, Bots ML, Peeters PH, van Staveren WA, Lamberts SW, Grobbee DE. Higher usual dietary intake of phytoestrogens is associated with lower aortic stiffness in postmenopausal women. Arterioscler Thromb Vasc Biol. 2002; 22: 1316–1322.

Halpern V, Song X, Faust GR. Estrogen inhibits elastase secretion from U937 cells via nitric oxide. Presented at the Lifeline Foundation Research Forum, Society of Vascular Surgery. June 8, 2003.

Seli E, Pehlivan T, Selam B, Garcia-Velasco JA, Arici A. Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells. Fertil Steril. 2002; 77: 542–547.

Jilma B, Jilma-Stohlawetz P. Female gender, menstrual cycle and estradiol affect plasma levels of monocyte chemotactic protein-1 (MCP-1) in humans. Cardiovasc Res. 2002; 55: 416.

Rodriguez E, Lopez R, Paez A, Masso F, Montano LF. 17?-estradiol inhibits the adhesion of leukocytes in TNF- stimulated human endothelial cells by blocking IL-8 and MCP-1 secretion, but not its transcription. Life Sciences. 2002; 71: 2181–2193.

Yamada K, Hayashi T, Kuzuya M, Naito M, Asai K, Iguchi A. Physiological concentration of 17 ?-estradiol inhibits chemotaxis of human monocytes in response to monocyte chemotactic protein 1. Artery. 1996; 22: 24–35.

Hibbs MS. Expression of 92 kDa phagocyte gelatinase by inflammatory and connective tissue cells. Matrix Supplement. 1992; 1: 51–57.

Curci JA, Thompson RW. "Variable induction of experimental abdominal aortic aneurysms with different preparations of porcine pancreatic elastase". J Vasc Surg. 1999; 29: 385.